NCT04039243

Brief Summary

The purpose of this study is to test the feasibility and efficacy of intervening with 2-year-old children with elevated temperamental Fear and/or Shyness or 3-year-old children with elevated anxiety and their parents, using a parent-child Cognitive Behavioral Therapy (CBT) protocol to reduce anxiety disorders and maintain reduced anxiety at one-year follow-up. Before the COVID-19 pandemic, study visits and treatment sessions were conducted in office. Now all visits and treatment sessions are conducted remotely.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
0mo left

Started Sep 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Sep 2019Jun 2026

First Submitted

Initial submission to the registry

July 29, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 31, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

September 27, 2019

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

January 15, 2026

Status Verified

January 1, 2026

Enrollment Period

5.9 years

First QC Date

July 29, 2019

Last Update Submit

January 13, 2026

Conditions

Keywords

Anxiety disordersToddlersPreschoolersCognitive-behavioral therapy

Outcome Measures

Primary Outcomes (2)

  • Response Rate (proportion of participants rated as 1 or 2 on Clinical Global Impression of Anxiety-Improvement Measure (CGI-I)

    The CGI-I is a 7-point scale from 1 (Very Much Improved) to 7 (Very Much Worse). It will be rated by a clinician interviewer blind to treatment condition

    Baseline to four-month follow-up

  • CGI-Severity Ratings

    Compared between groups at 4- and 8-month FU

Study Arms (3)

Active Treatment

EXPERIMENTAL

Up to 12 sessions of Parent-Child CBT using an adaptation of the Being Brave protocol

Behavioral: Being Brave

Parent Education

ACTIVE COMPARATOR

Parents receive educational materials about how to help young children overcome shyness and anxiety

Other: Parent Education

Monitoring

NO INTERVENTION

Interventions

Being BraveBEHAVIORAL

Up to 12 weekly sessions

Active Treatment

Parents receive educational materials about helping children overcome shyness and fear

Parent Education

Eligibility Criteria

Age21 Months - 47 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • The child scores \>1 Standard Deviation (SD) above reported means for the Fear or Shyness scales on the Early Childhood Behavior Questionnaire (ECBQ) (if child is 21-35 months) or the child scores \>1SD above reported means for the Total Anxiety, Generalized Anxiety, Social Anxiety, Physical Injury Fears, or Separation Anxiety scales on the Preschool Anxiety Scale (PAS) (if child is 36-47 months) as completed by a parent
  • The parents are able to speak, understand, and read English
  • The child must have a working knowledge of English.

You may not qualify if:

  • Autism Spectrum Disorder (ASD) or global developmental delay in the child
  • The child has disruptive behavior so severe as to interfere with participation in intervention sessions
  • The child has a different primary disorder for which CBT for anxiety is inappropriate (e.g. severe depression, depression in the mother, significant medical disorder).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

ShynessAnxiety Disorders

Condition Hierarchy (Ancestors)

Social BehaviorBehaviorMental Disorders

Study Officials

  • Dina Hirshfeld-Becker, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Co-Director, MGH Child CBT Program

Study Record Dates

First Submitted

July 29, 2019

First Posted

July 31, 2019

Study Start

September 27, 2019

Primary Completion

September 1, 2025

Study Completion (Estimated)

June 1, 2026

Last Updated

January 15, 2026

Record last verified: 2026-01

Locations